Guest guest Posted April 23, 2001 Report Share Posted April 23, 2001 FEAT DAILY NEWSLETTER Sacramento, California http://www.feat.org " Healing Autism: No Finer a Cause on the Planet " ______________________________________________________ April 23, 2001 Search www.feat.org/search/news.asp 2. MMR/Vaccine Report Finds No Provable Connection but Calls for Research Continued from previous post. SIGNIFICANCE ASSESSMENT In its significance assessment, the committee considered the burden (i.e., the seriousness, risk, and treatability) of the vaccine-preventable diseases (measles, mumps, and rubella). The potential adverse event (ASD), and the level of public concern surrounding this issue. Measles, mumps, and rubella can lead to significant morbidity and mortality and treatment of these infectious diseases and their associated complications is limited to symptomatic relief and physiologic support until the condition resolves. Historically, concerns about the safety of vaccines have led to declines in immunization coverage rates followed by outbreaks of disease, as observed with pertussis in the United Kingdom during the 1970s. Similar outbreaks could easily occur were immunization rates to decline as a result of fears regarding MMR. Yet, because MMR vaccine is a mandatory vaccine that is administered to healthy children—in part, as a public health measure to protect the health of others—the responsibility of the government to ensure the safety of this vaccine is high, even if the adverse outcome is rare. Thus the significance of the hypothesized adverse event—ASD, a group of incurable and serious behavioral disorder—requires consideration of all possible etiologies. In addition, the level of public concern about MMR vaccine safety is high. RECOMMENDATIONS Public Health Response Although the committee has concluded that the evidence favors rejection of the causal relationship at the population level between MMR vaccine and autistic spectrum disorders, the committee-nevertheless recommends that this issue receive continued attention. It does so in recognition that its conclusion does not exclude the possibility that MMR vaccine could contribute to ASD in a small number of children, as well as the following factors: the identified limitations of the evidence, the burden of ASD, the burden of the diseases prevented by the vaccine, the immense and concern of parents, and the prominence of the issue in public debate. Specific recommendations regarding policy review, research and surveillance, and communication follow. Policy Review The committee does not recommend a policy review at this time of the licensure of MMR vaccine or of the current schedule and recommendations for administration of MMR vaccine. Research Regarding MMR and ASD The committee concludes & at further research on the occurrence of ASD in a small number of children subsequent to MMR vaccination is warranted and has identified targeted research opportunities that could lead to firmer understanding of the relationship. The Committee makes the following research recommendations, recognizing that it has no basis for judging whether the results of such research will alter the balance of evidence that led to the committee's original conclusion: • Use accepted case definitions and assessment protocols for ASD to enhance the precision and comparability of results from surveillance, epidemiological studies, and biologic investigations. • Explore whether exposure to MMR vaccine is a risk factor for ASD in a small number of children. • Develop targeted investigation of whether or not measles vaccine-strain virus is present in the intestines of some children with ASD. • Encourage all who submit reports to the Vaccine Adverse Event Reporting System to provide as much detail and as much documentation as possible when any diagnosis of ASD is thought to be related to MMR vaccine, • Study the possible effects of different immunization exposures—for example, studying children whose families have chosen to have them not receive the MMR vaccine. • Conduct further clinical and epidemiological studies of sufficient rigor to identify risk factors and biological markers of ASD in order to better understand genetic or environmental causes. Communications » The committee heard repeatedly in its open sessions and discussions with parents and advocacy groups that obtaining unbiased and accurate information on the possible relationship between MMR vaccine and ASD has been difficult. The committee will address this issue more fully in the future. In the meantime, it specifically recommends that governmental and professional organizations, CDC and Food and Drug Administration (PDA) in particular, review some of the most prominent forms of communication regarding the hypothesized relationship between MMR vaccine and ASD, including ease of access to information they provide via the Internet. They should especially be attentive to how the material is perceived and used by parents of children about to be immunized or those who believe their child has been adversely affected by a vaccine. Direct input from parents and other stakeholders would be invaluable in conducting a systematic and effective evaluation of current communication tools. General and Crosscutting Issues In its discussion of recommendations related specifically to the MMR-ASD question, the committee identified more general concerns that it could not adequately or appropriately address in this report. These include: deficiencies in the available information on the risks and benefits of vaccines; inadequate discussion on the ethics of providing information regarding the risks and benefits of vaccinations; the role of public input into vaccine advisory committees; and inadequate clinical-provider information on vaccine safety or the Vaccine Adverse Event Reporting System. The committee sees a need for a dialogue between vaccine safety advocates of every kind, in order to come to common understanding of how to align the appropriate public health attention with a possibly small vaccine safety risk. Finally, the committee did not have time to responsibly address the appropriateness of alternative immunization schedules or practices, which might be requested in a clinical setting. These concerns will be more completely considered in future reports. In the meantime, the committee urges the CDC, PDA, NIH, American Academy of Pediatrics (AAP), and similar organizations to take to heart the serious concerns and earnest offers of help on information exchange and communication from the members of the public concerned about the safety of vaccines. SUMMARY The Immunization Safety Review Committee concludes that the evidence favors rejection of a causal relationship at the population level between MMR vaccine and ASD. However, this conclusion does not exclude the possibility that MMR vaccine could contribute to ASD in a small number of children, because the epidemiological evidence lacks the precision to assess rare occurrences of a response to MMR vaccine leading to ASD and the proposed biological models linking MMR vaccine to ASD, although far from established, are nevertheless not disproved. Because of the limitations of the evidence, the significant public concern surrounding the issue, the risk of disease outbreaks if immunization rates fall, and the seriousness of ASD, the committee recommends that continued attention be given to this issue. Thus the committee has provided targeted research and communication recommendations. However, the committee does not recommend a policy review at this time of the licensure of MMR vaccine or of the current schedule and recommendations regarding administration of MMR vaccine. >> DO SOMETHING ABOUT AUTISM NOW << Subscribe, Read, then Forward the FEAT Daily Newsletter. To Subscribe go to www.feat.org/FEATnews No Cost! _______________________________________________________ AUTISM CONFERENCE & RALLY! WASH DC APRIL 25-27 " Open Your Eyes to Autism " and be a part of " The Power of ONE " Unlocking Autism - www.UnlockingAutism.org _______________________________________________________ Lenny Schafer, Editor PhD Ron Sleith Kay Stammers Editor@... Unsubscribe: FEATNews-signoff-request@... CALENDAR OF EVENTS submissions to Guppy events@... Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.